Curis, Inc. (CRIS) Discusses Positive Data From Emavusertib Combination Study in Primary CNS Lymphoma Transcript
Curis, Inc. (CRIS) Discusses Positive Data From Emavusertib Combination Study in Primary CNS Lymphoma Transcript
Curis, Inc. (CRIS) Q1 2026 Earnings Call Transcript
Curis, Inc. (CRIS) Q1 2026 Earnings Call Transcript
Curis (CRIS) Upgraded to Buy: What Does It Mean for the Stock?
Curis (CRIS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Curis, Inc. (CRIS) Q4 2025 Earnings Call Transcript
Curis, Inc. (CRIS) Q4 2025 Earnings Call Transcript
Curis, Inc. (CRIS) Q3 2025 Earnings Call Transcript
Curis, Inc. ( CRIS ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Diantha Duvall - CFO and Principal Financial & Accounting Officer James Dentzer - President, CEO, Secretary, Treasurer & Director Ahmed Hamdy - Chief Medical Officer Conference Call Participants Sara Nik - H.C. Wainwright & Co, LLC, Research Division Li Wang Watsek - Cantor Fitzgerald & Co., Research Division Yale Jen - Laidlaw & Company (UK) Ltd.
Curis (CRIS) Reports Q3 Loss, Beats Revenue Estimates
Curis (CRIS) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to a loss of $1.7 per share a year ago.
Curis, Inc. (CRIS) Q2 2025 Earnings Call Transcript
Curis, Inc. (NASDAQ:CRIS ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Ahmed M. Hamdy - Chief Medical Officer Diantha Duvall - CFO and Principal Financial & Accounting Officer James E.
Curis (CRIS) Reports Q2 Loss, Beats Revenue Estimates
Curis (CRIS) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $1.99. This compares to a loss of $2.03 per share a year ago.
Curis, Inc. (CRIS) Q1 2025 Earnings Call Transcript
Curis, Inc. (NASDAQ:CRIS ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Diantha Duvall - Chief Financial Officer Jim Dentzer - President & Chief Executive Officer Ahmed Hamdy - Chief Medical Officer Jonathan Zung - Chief Development Officer Conference Call Participants Li Watsek - Cantor Fitzgerald Kripa Devarakonda - Truist Securities Operator Good morning ladies and gentlemen and welcome to the Curis Provides First Quarter 2025 Business Update Conference Call. At this time, all lines are in listen-only mode.
Curis (CRIS) Reports Q1 Loss, Tops Revenue Estimates
Curis (CRIS) came out with a quarterly loss of $1.25 per share versus the Zacks Consensus Estimate of a loss of $1.14. This compares to loss of $2.05 per share a year ago.
Curis, Inc. (CRIS) Q4 2024 Earnings Call Transcript
Curis, Inc. (NASDAQ:CRIS ) Q4 2024 Earnings Conference Call March 31, 2025 8:30 AM ET Company Participants Diantha Duvall - CFO Jim Dentzer - President and CEO Jonathan Zung - Chief Development Officer Conference Call Participants Sean McCutcheon - Raymond James Li Watsek - Cantor Fitzgerald Ed White - H.C. Wainwright Operator Good morning, and welcome to Curis's Fourth Quarter 2024 Business Update Call.
Curis, Inc. (CRIS) Q3 2024 Earnings Call Transcript
Curis, Inc. (NASDAQ:CRIS ) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Company Participants Diantha Duvall - Chief Financial Officer Jim Dentzer - President & Chief Executive Officer Jonathan Zung - Chief Development Officer Conference Call Participants Ed White - H.C. Wainwright Billal Jahangiri - Truist Securities Daniel Bronder - Cantor Sean McCutcheon - Raymond James Operator Good morning, ladies and gentlemen, and welcome to the Curis Third Quarter 2024 Business Update Call.
